China Rotavirus Vaccine Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Rotavirus Vaccine market is growing globally due to the rising burden of rotavirus infection, government immunization programs, increasing awareness and education about rotavirus infection, improved vaccine coverage, research and development activities to improve the safety and efficacy of rotavirus vaccine, international support from world health organization. Merck & Co., Inc., Bharat Biotech, GlaxoSmithKline plc., Sanofi, Lanzhou Institute of Biologicals Products Co., Ltd, BIOVIRx Inc, Serum Institute of India Pvt. Ltd., Biological E, Bio Farma, Novartis AG, Berghofer Medical Research Institute, Pfizer, Inc., CSL Limited, Emergent BioSolutions, Inc., Johnson & Johnson Services, Inc., AstraZeneca, Bavarian Nordic, Mitsubishi Tanabe Pharma Corporation., DAIICHI SANKYO COMPANY, LIMITED are the key global market players in rotavirus vaccine market.
China Rotavirus Vaccine Market is valued at around $694 Mn in 2022 and is projected to reach $1434.4 Mn by 2030, exhibiting a CAGR of 9.5% during the forecast period 2023-2030.
Rotavirus infections, which can cause severe diarrhea in young children, are protected against by the rotavirus vaccine. Rotavirus infections can cause severe diarrhea, vomiting, fever, and abdominal pain as well as other symptoms. The oral rotavirus vaccine needs to be administered in two or three doses beginning at roughly six weeks of age. Live attenuated oral vaccinations and inactivated parenteral vaccines are the two primary forms of rotavirus vaccines now available. Live attenuated oral vaccines are taken orally and contain attenuated (weakened) rotavirus strains. The two most widely used oral vaccinations are RotaTeq and Rotarix, both created by Merck & Co., Inc. and GlaxoSmithKline, respectively. Inactivated parenteral vaccines these vaccines are given intravenously and include rotavirus particles that have been inactivated (killed). Bharat Biotech International Limited created Rotavac, one of the inactivated rotavirus vaccines. The majority of the market is dominated by live attenuated oral vaccinations like RotaTeq and Rotarix, which are the most popular. Merck & Co., Inc., Bharat Biotech, GlaxoSmithKline plc., Sanofi, Lanzhou Institute of Biologicals Products Co., Ltd, BIOVIRx Inc, Serum Institute of India Pvt. Ltd., Biological E, Bio Farma, Novartis AG, Berghofer Medical Research Institute, Pfizer, Inc., CSL Limited, Emergent BioSolutions, Inc., Johnson & Johnson Services, Inc., AstraZeneca, Bavarian Nordic, Mitsubishi Tanabe Pharma Corporation., DAIICHI SANKYO COMPANY, LIMITED are the key global market players in rotavirus vaccine market.
Market Growth Drivers
The rising burden of rotavirus infection, government immunization programs, increasing awareness and education about rotavirus infection, improved vaccine coverage, research and development activities to improve the safety and efficacy of rotavirus vaccine, and international support from the World Health Organization act as market growth drivers.
Market Restraints
Vaccine affordability issues, supply chain, and cold chain requirements as rotavirus vaccines require specific storage and transport conditions including a cold chain, vaccine safety concerns act as market growth restraints.
Key Players
1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
By type
By End Users
By Application
Methodology for Database Creation
Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.
Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.
How Do We Get It?
Our database is created and maintained through a combination of secondary and primary research methodologies.
1. Secondary Research
With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:
With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:
2. Primary Research
To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:
Combining Secondary and Primary Research
By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:
Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.